Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Clinical Medicine
|
March 19, 2020
Impact of Morphine Treatment on Infarct Size and Reperfusion Injury in Acute Reperfused ST-Elevation Myocardial Infarction
Ingo Eitel, Juan Wang, Thomas Stiermaier, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 29, 2021
Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience
Mohammed Saad, Osama Risha, Makoto Sano, et al.
European Heart Journal
|
September 1, 2024
Glycoprotein IIb/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial
Ingo Eitel, Roza Saraei, Dominik Jurczyk, et al.
ESC Heart Failure
|
November 16, 2021
Atrial appendage closure in patients with heart failure and atrial fibrillation: industry-independent single-centre study
Mohammed Saad, Mohamed Osman, Hosam Hasan-Ali, et al.
American Heart Journal
|
September 14, 2025
Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial
Ulf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
May 24, 2025
Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trial
Melanie Arnreiter, Moritz von Scheidt, Johannes M Albes, et al.
The New England Journal of Medicine
|
March 18, 2026
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
Ulf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.
American Heart Journal
|
September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial
Antoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trial
Tobias Heer, Moritz von Scheidt, Andreas Boening, et al.
European Heart Journal
|
May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial
Heribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Clinical Medicine
|
March 19, 2020
Impact of Morphine Treatment on Infarct Size and Reperfusion Injury in Acute Reperfused ST-Elevation Myocardial Infarction
Ingo Eitel, Juan Wang, Thomas Stiermaier, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 29, 2021
Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience
Mohammed Saad, Osama Risha, Makoto Sano, et al.
European Heart Journal
|
September 1, 2024
Glycoprotein IIb/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial
Ingo Eitel, Roza Saraei, Dominik Jurczyk, et al.
ESC Heart Failure
|
November 16, 2021
Atrial appendage closure in patients with heart failure and atrial fibrillation: industry-independent single-centre study
Mohammed Saad, Mohamed Osman, Hosam Hasan-Ali, et al.
American Heart Journal
|
September 14, 2025
Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial
Ulf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
May 24, 2025
Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trial
Melanie Arnreiter, Moritz von Scheidt, Johannes M Albes, et al.
The New England Journal of Medicine
|
March 18, 2026
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
Ulf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.
American Heart Journal
|
September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial
Antoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trial
Tobias Heer, Moritz von Scheidt, Andreas Boening, et al.
European Heart Journal
|
May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial
Heribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
Page
of 2